Your browser doesn't support javascript.
loading
A phase II study of capecitabine and cisplatin (XP) as first-line chemotherapy in patients with advanced esophageal squamous cell carcinoma.
Lee, Jeeyun; Im, Young-Hyuck; Cho, Eun Yoon; Hong, Yong Sang; Lee, Hyo Rak; Kim, Hyo Song; Kim, Mi-Jin; Kim, Kwhanmien; Kang, Won Ki; Park, Keunchil; Shim, Young Mog.
Afiliación
  • Lee J; Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Ilwon-dong, Kangnam-gu, Seoul 135-710, Korea.
Cancer Chemother Pharmacol ; 62(1): 77-84, 2008 Jun.
Article en En | MEDLINE | ID: mdl-17762932
Buscar en Google
Banco de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Chemother Pharmacol Año: 2008 Tipo del documento: Article
Buscar en Google
Banco de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Chemother Pharmacol Año: 2008 Tipo del documento: Article